Repligen Corporation (RGEN)

Repligen Market Cap

Repligen has a market cap or net worth of $8.91 billion as of February 21, 2025. Its market cap has decreased by -20.43% in one year.

• Market Cap: 8.91B
• Enterprise Value: 8.80B
• 1-Year Change: -20.43%
• Ranking: #947
• Category: Mid-Cap
• Stock Price: $158.99

Market Cap Chart

Since December 1, 1998, Repligen's market cap has increased from $28.10M to $8.91B, an increase of 31,599.96%. That is a compound annual growth rate of 24.54%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	8.91B	10.46%
Dec 31, 2024	8.06B	-19.67%
Dec 29, 2023	10.04B	6.78%
Dec 30, 2022	9.40B	-35.80%
Dec 31, 2021	14.64B	45.21%
Dec 31, 2020	10.08B	109.40%
Dec 31, 2019	4.82B	108.18%
Dec 31, 2018	2.31B	46.35%
Dec 29, 2017	1.58B	51.58%
Dec 30, 2016	1.04B	11.88%
Dec 31, 2015	932.00M	43.85%
Dec 31, 2014	647.90M	48.87%
Dec 31, 2013	435.20M	122.72%
Dec 31, 2012	195.40M	83.30%
Dec 30, 2011	106.60M	-26.18%
Dec 31, 2010	144.40M	14.24%
Dec 31, 2009	126.40M	7.21%
Dec 31, 2008	117.90M	-41.78%
Dec 31, 2007	202.50M	137.12%
Dec 29, 2006	85.40M	-29.07%
Dec 30, 2005	120.40M	39.03%
Dec 31, 2004	86.60M	-33.64%
Dec 31, 2003	130.50M	57.04%
Dec 31, 2002	83.10M	28.04%
Dec 31, 2001	64.90M	-27.65%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B